Drug Profile
FROST 700
Alternative Names: FROST-700Latest Information Update: 28 Aug 2020
Price :
$50
*
At a glance
- Originator Frost Biologic
- Class Antineoplastics; Small molecules
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes - Gastric cancer
Highest Development Phases
- No development reported Gastric cancer
Most Recent Events
- 28 Aug 2020 No recent reports of development identified for research development in Gastric-cancer in USA (PO)
- 28 Jul 2016 FROST 700 is available for licensing as of 28 Jul 2016. http://www.frostbiologic.com/partnering/
- 28 Jul 2016 Early research in Gastric cancer in USA (PO)